Prot #BTCRC-LUN19-396: A Phase II Study of Adjuvant Treatment with Cisplatin-Based Chemotherapy Plus Concomitant Atezolizumab in Patients with Stage I (Tumors = 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-Small Cell Lung C

Project: Research project

Project Details

StatusActive
Effective start/end date10/21/20 → 10/21/26

Funding

  • Hoosier Cancer Research Network, Inc. ((OE) Prot #BTCRC-LUN19-396 // (OE) Prot #BTCRC-LUN19-396)
  • Genentech, Inc ((OE) Prot #BTCRC-LUN19-396 // (OE) Prot #BTCRC-LUN19-396)